Mineralys Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2024 | — | $328.0M | $90.4M |
| Jun 2024 | — | $290.1M | $67.9M |
| Sep 2024 | — | $236.9M | $97.3M |
| Dec 2024 | — | $191.3M | $114.1M |
| Mar 2025 | — | $341.6M | $165.0M |
| Jun 2025 | — | $313.6M | $101.8M |
| Sep 2025 | — | $576.4M | $217.6M |
| Dec 2025 | — | $646.7M | $172.9M |
| Mar 2026 | — | $638.1M | $112.8M |
| Jun 2026 | $100.0K | $550.9M | $138.3M |